Drugs News and Research

RSS

UAB researchers show how to identify non-responding tumors and improve immunotherapy response

Immunotherapy using checkpoint inhibitors can work well to treat cancer, but only a minority of patients respond to therapy.

28 Oct 2021

A novel approach to improve the stability of Remdesivir

A recent study discusses a novel method to enhance the stability of Remdesivir.

28 Oct 2021

Combining clinical and EEG factors can help better predict treatment response in epilepsy patients

Combining electroencephalogram (EEG) data with clinical observations can help doctors to better determine whether generalized epilepsy patients will respond to treatment, according to a study led by Rutgers researchers.

28 Oct 2021

Diet-associated molecules in the gut are linked with aggressive prostate cancer

Cleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, suggesting dietary interventions may help reduce risk. Findings from the study were published in Cancer Epidemiology, Biomarkers & Prevention.

28 Oct 2021

'Theta activity' in the brain found to be divergent for people with mental health conditions

A new review of current literature, conducted by the Institute of Psychiatry, Psychology & Neuroscience at King's College London, has found that irregular responses in the brain to challenging tasks and mistakes could be key to understanding common links between abnormal behaviors in a range of mental illness and cognitive disorders.

28 Oct 2021

Study offers hope for a new therapeutic option for patients with severe asthma

A new monoclonal antibody therapy shows promise in offering an alternative treatment for patients suffering from moderate-to-severe asthma. Research led by Michael E. Wechsler, MD, MMSc, director of the National Jewish Health Cohen Family Asthma Institute, found that itepekimab was safe and effective in a phase 2 trial published online today in the New England Journal of Medicine.

28 Oct 2021

KHN’s ‘What the Health?’: Biden social-spending ‘framework’ pulls back on key health pledges

President Joe Biden unveiled a purported compromise on his social-spending plan shortly before taking off for a series of meetings in Europe.

28 Oct 2021

Immune cell patterns can help predict if kidney cancer patients will respond to immunotherapy

Researchers at the Francis Crick Institute, The Royal Marsden NHS Foundation Trust and UCL have found immune cell patterns within tumors that can help predict if patients with kidney cancer will respond to immunotherapy.

28 Oct 2021

Structure of human-infecting canine coronavirus HuPn-2018 spike glycoprotein

As CCoV-HuPn-2018 has been recently isolated in a child's respiratory swab, researchers from the University Of Washington have been examining the structure of the virus.

28 Oct 2021

Democrats’ plans to expand Medicare benefits put pinch on advantage plans’ funding

"Did you think we wouldn't notice?" an older woman says, speaking into the camera. "You thought you could sneak this through?" an older man later adds. Others warn that Washington is "messing with" their Medicare Advantage health coverage and trying to raise their premiums.

28 Oct 2021

Using fluvoxamine to treat COVID-19 patients reduces the need for prolonged hospitalization, trial shows

The results of a new randomized clinical trial, published in The Lancet Global Health, have demonstrated that using fluvoxamine to treat high-risk outpatients with early-diagnosed COVID-19 reduced the need for prolonged observation in an emergency setting or hospitalization, compared to a control group who received a placebo.

28 Oct 2021

New system created for targeted delivery of anti-cancer drugs

RUDN University and Shahid Beheshti University (SBU) chemist together with colleagues from Iran created a system for targeted delivery of anti-cancer drugs.

27 Oct 2021

A low-cost repurposed drug can save COVID-19 patients' lives

An inexpensive repurposed drug called fluvoxamine can save the lives of COVID-19 patients and cut hospital admissions by up to 30 per cent, says a study co-led by McMaster University.

27 Oct 2021

New mechanisms for treating impregnable KRAS mutant cancers with statins

Third-generation cancer immunotherapy, a method of removing cancer using the body's immune system, has shown remarkable clinical benefits in recent years, giving hopes to many researchers and patients.

27 Oct 2021

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

A new study identifies a potent SARS-CoV-2 antiviral, Pheophorbide a (PheoA), which is a compound derived from the plant Marchantia polymorpha L.

27 Oct 2021

COVID-19 and subacute neuropsychiatric symptoms in adolescents

A new paper discusses neurologic symptoms in children with COVID-19.

27 Oct 2021

Taking lessons in molecular therapeutics from earthworms to combat COVID

Scientists were interested in further investigating the defense mechanism of earthworms in an effort to discover therapeutic solutions against SARS-CoV-2.

27 Oct 2021

Physical therapy associated with lower odds of long-term opioid use after total knee replacement

The world's most common form of arthritis, knee osteoarthritis, causes sufferers pain and hurts their quality of life.

27 Oct 2021

Ensemble-based machine learning algorithms accurately predict anti-cancer drug responses

Today, machine learning, artificial intelligence, and algorithmic advancements made by research scientists and engineers are driving more targeted medical therapies through the power of prediction.

27 Oct 2021

Study uncovers how novel coronavirus disrupts normal cell defenses to hijack human host cells

A UBC-led research team has uncovered how the virus responsible for causing COVID-19 escapes destruction in infected cells, allowing SARS-CoV-2 to persist and continue spreading in the human body.

27 Oct 2021

Drugs News and Research

UAB researchers show how to identify non-responding tumors and improve immunotherapy response

A novel approach to improve the stability of Remdesivir

Combining clinical and EEG factors can help better predict treatment response in epilepsy patients

Diet-associated molecules in the gut are linked with aggressive prostate cancer

'Theta activity' in the brain found to be divergent for people with mental health conditions

Study offers hope for a new therapeutic option for patients with severe asthma

KHN’s ‘What the Health?’: Biden social-spending ‘framework’ pulls back on key health pledges

Immune cell patterns can help predict if kidney cancer patients will respond to immunotherapy

Structure of human-infecting canine coronavirus HuPn-2018 spike glycoprotein

Democrats’ plans to expand Medicare benefits put pinch on advantage plans’ funding

Using fluvoxamine to treat COVID-19 patients reduces the need for prolonged hospitalization, trial shows

New system created for targeted delivery of anti-cancer drugs

A low-cost repurposed drug can save COVID-19 patients' lives

New mechanisms for treating impregnable KRAS mutant cancers with statins

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

COVID-19 and subacute neuropsychiatric symptoms in adolescents

Taking lessons in molecular therapeutics from earthworms to combat COVID

Physical therapy associated with lower odds of long-term opioid use after total knee replacement

Ensemble-based machine learning algorithms accurately predict anti-cancer drug responses

Study uncovers how novel coronavirus disrupts normal cell defenses to hijack human host cells

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News